Literature DB >> 19059417

Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.

Gautier Robin1, Keith Chappell, Martin J Stoermer, Shu-Hong Hu, Paul R Young, David P Fairlie, Jennifer L Martin.   

Abstract

Over the last decade, West Nile virus has spread rapidly via mosquito transmission from infected migratory birds to humans. One potential therapeutic approach to treating infection is to inhibit the virally encoded serine protease that is essential for viral replication. Here we report the crystal structure of the viral NS3 protease tethered to its essential NS2B cofactor and bound to a potent substrate-based tripeptide inhibitor, 2-naphthoyl-Lys-Lys-Arg-H (K(i)=41 nM), capped at the N-terminus by 2-naphthoyl and capped at the C-terminus by aldehyde. An important and unexpected feature of this structure is the presence of two conformations of the catalytic histidine suggesting a role for ligand stabilization of the catalytically competent His conformation. Analysis of other West Nile virus NS3 protease structures and related serine proteases supports this hypothesis, suggesting that the common catalytic mechanism involves an induced-fit mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059417     DOI: 10.1016/j.jmb.2008.11.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

2.  Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.

Authors:  René Assenberg; Eloise Mastrangelo; Thomas S Walter; Anil Verma; Mario Milani; Raymond J Owens; David I Stuart; Jonathan M Grimes; Erika J Mancini
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

3.  Fusion-protein-assisted protein crystallization.

Authors:  Bostjan Kobe; Thomas Ve; Simon J Williams
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-06-27       Impact factor: 1.056

4.  Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

Authors:  Laura A VanBlargan; Kaitlin A Davis; Kimberly A Dowd; David L Akey; Janet L Smith; Theodore C Pierson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 5.  Functional interplay among the flavivirus NS3 protease, helicase, and cofactors.

Authors:  Kuohan Li; Wint Wint Phoo; Dahai Luo
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

6.  Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.

Authors:  Sergey A Shiryaev; Anton V Cheltsov; Katarzyna Gawlik; Boris I Ratnikov; Alex Y Strongin
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

7.  Structure-guided fragment-based in silico drug design of dengue protease inhibitors.

Authors:  Tim Knehans; Andreas Schüller; Danny N Doan; Kassoum Nacro; Jeffrey Hill; Peter Güntert; M S Madhusudhan; Tanja Weil; Subhash G Vasudevan
Journal:  J Comput Aided Mol Des       Date:  2011-02-23       Impact factor: 3.686

8.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Ligand-bound structures of the dengue virus protease reveal the active conformation.

Authors:  Christian G Noble; Cheah Chen Seh; Alexander T Chao; Pei Yong Shi
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

10.  NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease.

Authors:  Xun-Cheng Su; Kiyoshi Ozawa; Ruhu Qi; Subhash G Vasudevan; Siew P Lim; Gottfried Otting
Journal:  PLoS Negl Trop Dis       Date:  2009-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.